Description |
fatty acid 2-hydroxylase |
ER lipid raft associated 1 |
Image |
No pdb structure |
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- General cognitive ability ( 25383866)
- Pancreatic cancer ( 25086665)
- White matter lesion progression (adjusted for white matter lesion burden at baseline) ( 26451028)
|
- Apolipoprotein A1 levels ( 32203549)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- General cognitive ability ( 29844566)
- HDL cholesterol ( 30275531)
- HDL cholesterol levels ( 32203549)
- Heel bone mineral density ( 30598549)
- Liver enzyme levels ( 18940312)
- Refractive error ( 32231278)
- Response to radiotherapy in cancer (late toxicity) ( 24785509)
- Squamous cell lung carcinoma ( 28604730)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
|
Interacting Genes |
31 interacting genes:
AQP6
ARMC12
ASGR2
CD79A
CREB3
CREB3L1
DLG2
EBP
ELOVL4
ERGIC3
ERLIN1
FAM209A
FCER1G
GPR152
GPR37
GPX8
LMNA
MARCHF8
MSR1
PEX12
PGRMC2
RIC3
SGPL1
SLC10A1
SLC10A6
SYT2
TLCD4
TMEM14B
TMEM41A
TMX2
UBQLN4
|
7 interacting genes:
AGR3
BNIP2
FA2H
RBFA
SEC22A
SEC23A
TMEM199
|
Entrez ID |
79152 |
10613 |
HPRD ID |
16873 |
08502 |
Ensembl ID |
ENSG00000103089
|
ENSG00000107566
|
Uniprot IDs |
Q7L5A8
|
O75477
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|